Related Experiment Video
Updated: May 11, 2025
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Correlation between total IgE level and asthma symptom severity in hospitalized children
Tasmia Rezwan1, Michelle Perez2, Sarah Jacobs3
1Good Samaritan University Hospital, West Islip, NY.
Background:
Status asthmaticus is a common reason for hospitalization and pediatric intensive care unit (PICU) admission among children. While previous studies have demonstrated a correlation between elevated IgE levels and asthma severity in outpatient settings, studies analyzing IgE levels in an inpatient cohort are limited.
Objective:
We examined the relationship between baseline IgE levels and symptom severity, maximum respiratory support, and PICU and hospital length of stay in an inpatient pediatric cohort.
Methods:
This was a single-center retrospective chart review of children admitted to the Children's Hospital at Montefiore with status asthmaticus as their primary diagnosis. The primary goal was to determine the relationship between baseline IgE levels and severity of illness at time of admission. Secondary outcomes included maximum respiratory support, and PICU and hospital length of stay.
Results:
We identified a statistically significant difference (P = .043) in baseline IgE levels between the PICU (median, 608 U/mL) and floor groups (405 IU/mL). There was a positive correlation between IgE level and PICU length of stay (P = .004).
Conclusion:
Elevated baseline IgE level is correlated with higher asthma symptom severity when hospitalized and with longer PICU length of stay. Our study adds to the growing body of evidence that those with high baseline IgE levels are at risk of having severe asthma symptomology.
Related Concept Videos
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:29Asthma-I: Introduction
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.